Aprovasc 300/5mg Tablets 28’s

Description
Irbesartan/amlodipine (Aprovasc®) is an angiotensin-receptor blocker/calcium-channel blocker fixed-dose single-pill combination, whose constituent drugs exert additive effects when coadministered. It is indicated in patients whose blood pressure is not adequately controlled on irbesartan or amlodipine monotherapy. Irbesartan and Amlodipine: The pharmacodynamic properties of each drug, Irbesartan and Amlodipine, provide an addition of antihypertensive effects when administered in combination against the effect observed with both components separately. Both the AT1 receptor blocker and the calcium channel antagonist lower blood pressure by reducing peripheral resistance, but blocking calcium flow and reducing vasoconstriction by angiotensin II are complementary mechanisms. Irbesartan: Mechanism of action: Irbesartan is a specific antagonist of angiotensin II receptors (AT1 subtype). Angiotensin II is an important component of the renin-angiotensin system, it participates in the pathophysiology of hypertension and in sodium homeostasis. Irbesartan does not require metabolic activation for its action. Irbesartan blocks the potent vasoconstriction and aldosterone secretion effects produced by angiotensin II, by selective antagonism of angiotensin II receptors (AT1 subtype) located in vascular smooth muscle cells and in the adrenal cortex. Irbesartan has no agonist activity at the AT1 receptor and has a much higher affinity (more than 8,500 times) for the AT1 receptor than for the AT2 receptor (a receptor that has not been shown to be associated with cardiovascular homeostasis). Irbesartan does not inhibit the enzymes that participate in the renin-angiotensin system, that is, the angiotensin-converting enzyme (ACE), nor does it affect other hormone receptors or ion channels that are involved in the cardiovascular regulation of blood pressure and in sodium homeostasis. AT1 receptor blockade caused by irbesartan disrupts the feedback loop within the renin-angiotensin system, resulting in increases in plasma renin and angiotensin II levels.
How to use
Follow exactly the instructions of Aprovasc ® given by your doctor. Ask your doctor or pharmacist if you have questions. The usual dose of Aprovasc ® is 1 tablet a day. It can be administered with or without food by mouth with a sufficient amount of liquid. You should try to take your daily dose at the same time each day. It is important that you continue taking Aprovasc ® until your doctor advises you otherwise.
Precautions
Due to the presence of both irbesartan and amlodipine, Aprovasc ® is contraindicated in: Hypersensitivity to both the active substances or any component of the formulation. Hypersensitivity to dihydropyridines. Cardiogenic shock, clinically significant aortic stenosis, unstable angina (excluding Prinzmetal’s angina). Pregnancy and lactation (see Warnings and Pregnancy and Lactation sections). -Do not co-administer Aprovasc ® with aliskiren-containing medicinaDue to the presence of both irbesartan and amlodipine, Aprovasc ® is contraindicated in: Hypersensitivity to both the active substances or any component of the formulation. Hypersensitivity to dihydropyridines. Cardiogenic shock, clinically significant aortic stenosis, unstable angina (excluding Prinzmetal’s angina). Pregnancy and lactation (see Warnings and Pregnancy and Lactation sections). -Do not co-administer Aprovasc ® with aliskiren-containing medicinal products in patients with diabetes or with moderate to severe renal insufficiency (glomerular filtration rate (IFG) <60 ml / min / 1.73 m 2 ). Do not co-administer Aprovasc ® with ACE inhibitors (angiotensin converting enzyme inhibitors) in patients with diabetic l products in patients with diabetes or with moderate to severe renal insufficiency (glomerular filtration rate (IFG) <60 ml / min / 1.73 m 2 ). Do not co-administer Aprovasc ® with ACE inhibitors (angiotensin converting enzyme inhibitors) in patients with diabetic nephropathy.

KShs 5,100.00

20 People watching this product now!

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Online Sports Nutrition and Natural Dietetics.

Chances are there wasn't collaboration, communication, and checkpoints, there wasn't a process agreed upon or specified with the granularity required. It's content strategy gone awry right from the start. Forswearing the use of Lorem Ipsum wouldn't have helped, won't help now. It's like saying you're a bad designer, use less bold text, don't use italics in every other paragraph. True enough, but that's not all that it takes to get things back on track.

The villagers are out there with a vengeance to get that Frankenstein

You made all the required mock ups for commissioned layout, got all the approvals, built a tested code base or had them built, you decided on a content management system, got a license for it or adapted:

  • The toppings you may chose for that TV dinner pizza slice when you forgot to shop for foods, the paint you may slap on your face to impress the new boss is your business.
  • But what about your daily bread? Design comps, layouts, wireframes—will your clients accept that you go about things the facile way?
  • Authorities in our business will tell in no uncertain terms that Lorem Ipsum is that huge, huge no no to forswear forever.
  • Not so fast, I'd say, there are some redeeming factors in favor of greeking text, as its use is merely the symptom of a worse problem to take into consideration.
  • Websites in professional use templating systems.
  • Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template.
  • When it's about controlling hundreds of articles, product pages for web shops, or user profiles in social networks, all of them potentially with different sizes, formats, rules for differing elements things can break, designs agreed upon can have unintended consequences and look much different than expected.

This is quite a problem to solve, but just doing without greeking text won't fix it. Using test items of real content and data in designs will help, but there's no guarantee that every oddity will be found and corrected. Do you want to be sure? Then a prototype or beta site with real content published from the real CMS is needed—but you’re not going that far until you go through an initial design cycle.